Login
Neurocrine Biosciences Inc logo

Neurocrine Biosciences Inc

neurocrine.com

Neurocrine Biosciences (NASDAQ: NBIX) is a biopharmaceutical company that develops and commercializes medicines for neurological and endocrine-related diseases. The filing excerpts provided do not contain sufficient detail to describe specific revenue figures, product names, segment breakdowns, market position, or other business specifics for FY2025. The 10-K was filed on 2026-02-11 under accession number 000091447526000007, but the substantive business, financial, and product content from the filing was not included in the excerpts made available for this summary. A complete description will require access to the full Item 1 Business section and financial statements from that filing.

Financial Snapshot

Revenue
TTM
$3.374B
Gross Margin
TTM
98.12%
Net Income
TTM
$705.5M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
187.25%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
$3.694B
Cash
2026 Q2
P/E
TTM
23.77
Free Cash Flow
TTM
$741.8M

Stock Price

Loading...
Market Cap: $16.772 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support